Skip to main content

Cigarette Smoking

2
Pipeline Programs
6
Companies
9
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
1
VareniclinePhase 41 trial
Active Trials
NCT02488889Withdrawn0Est. Jul 2016
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
Break the ChainPhase 21 trial
Active Trials
NCT02602730Completed307Est. Aug 2013
Human BioSciences
Human BioSciencesWV - Martinsburg
4 programs
Academic DetailingN/A1 trial
Best PracticesN/A1 trial
Best practicesN/A1 trial
Receipt of Genetic ResultsN/A1 trial
Active Trials
NCT02845440Completed1,165Est. Jan 2021
NCT05740098Completed198Est. Oct 2020
NCT02210832Completed257Est. Jan 2020
+1 more trials
Pfizer
PfizerNEW YORK, NY
1 program
Smoking Cessation Decision AidsN/A1 trial
Active Trials
NCT01566097Unknown400Est. Jul 2015
Intelligent Therapeutics
1 program
mSMART smartphone applicationN/A1 trial
Active Trials
NCT02072005Completed11Est. Apr 2014
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Nicotine replacement therapy - transdermal nicotine patchPHASE_21 trial
Active Trials
NCT01592695CompletedEst. Jun 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsVarenicline
City TherapeuticsNicotine replacement therapy - transdermal nicotine patch
Oregon TherapeuticsBreak the Chain
Human BioSciencesAcademic Detailing
Human BioSciencesBest Practices
Intelligent TherapeuticsmSMART smartphone application
Human BioSciencesBest practices
Human BioSciencesReceipt of Genetic Results
PfizerSmoking Cessation Decision Aids

Clinical Trials (9)

Total enrollment: 2,362 patients across 9 trials

NCT02488889Angeles TherapeuticsVarenicline

Effects of Varenicline in Heavy Drinking Smokers

Start: Aug 2015Est. completion: Jul 20160
Phase 4Withdrawn
NCT01592695City TherapeuticsNicotine replacement therapy - transdermal nicotine patch

Tailored Tobacco Quitline for Rural Veterans

Start: Jun 2012Est. completion: Jun 2013
Phase 2Completed
NCT02602730Oregon TherapeuticsBreak the Chain

Internet-Based Nonsmoking Program for Postpartum Women

Start: Feb 2012Est. completion: Aug 2013307 patients
Phase 2Completed
NCT02845440Human BioSciencesAcademic Detailing

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

Start: Jul 2016Est. completion: Jan 20211,165 patients
N/ACompleted
NCT05740098Human BioSciencesBest Practices

Financial Incentives for Smoking Cessation Among Mothers

Start: Jun 2015Est. completion: Oct 2020198 patients
N/ACompleted
NCT02072005Intelligent TherapeuticsmSMART smartphone application

Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills

Start: Feb 2014Est. completion: Apr 201411 patients
N/ACompleted
NCT02210832Human BioSciencesBest practices

Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women

Start: Jan 2014Est. completion: Jan 2020257 patients
N/ACompleted
NCT01780038Human BioSciencesReceipt of Genetic Results

Smokers' Response to Nicotine Dependence Genotyping

Start: Nov 2012Est. completion: Aug 201324 patients
N/ACompleted
NCT01566097PfizerSmoking Cessation Decision Aids

Intervention Trial of Culturally-Appropriate Decision Aids for Smoking Cessation

Start: Apr 2012Est. completion: Jul 2015400 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.